• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?

作者信息

Erre Gian Luca, Ferraccioli Edoardo Sean, Piga Matteo, Mangoni Arduino, Passiu Giuseppe, Gremese Elisa, Ferraccioli Gianfranco

机构信息

Dipartimento di Specialità Mediche, Chirurgiche e Sperimentali, Università degli Studi di Sassari, Sassari, Italy

Pediatrics, Universita degli Studi di Verona, Verona, Veneto, Italy.

出版信息

Ann Rheum Dis. 2021 Mar;80(3):e29. doi: 10.1136/annrheumdis-2020-217828. Epub 2020 May 18.

DOI:10.1136/annrheumdis-2020-217828
PMID:32424028
Abstract
摘要

相似文献

1
Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?新型冠状病毒肺炎和风湿性疾病患者中抗疟药的使用与心律失常：剂量和炎症问题？
Ann Rheum Dis. 2021 Mar;80(3):e29. doi: 10.1136/annrheumdis-2020-217828. Epub 2020 May 18.
2
Response to: 'Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?' by Erre .
Ann Rheum Dis. 2021 Mar;80(3):e30. doi: 10.1136/annrheumdis-2020-217923. Epub 2020 May 18.
3
Antimalarial drugs in the treatment of rheumatological diseases.抗疟药物在风湿病治疗中的应用。
Br J Rheumatol. 1998 May;37(5):580. doi: 10.1093/rheumatology/37.5.580b.
4
Still early to define a clear role of antimalarial drugs for COVID-19 in patients with rheumatic disease. Response to: 'Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?' by Xie .对于抗疟药物在风湿性疾病患者的新型冠状病毒肺炎治疗中明确作用的界定仍为时过早。回应：谢的“羟氯喹降低风湿性疾病患者感染新型冠状病毒肺炎的风险：神话还是现实？”
Ann Rheum Dis. 2021 Jan;80(1):e7. doi: 10.1136/annrheumdis-2020-217633. Epub 2020 Jun 22.
5
Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action.重新评估抗疟药在治疗风湿性疾病中的作用：对新作用机制的再认识和深入了解。
Curr Opin Rheumatol. 2011 May;23(3):278-81. doi: 10.1097/BOR.0b013e32834456bf.
6
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.风湿性疾病患者因 COVID-19 住院的相关特征：来自 COVID-19 全球风湿病联盟医生报告登记处的数据。
Ann Rheum Dis. 2020 Jul;79(7):859-866. doi: 10.1136/annrheumdis-2020-217871. Epub 2020 May 29.
7
Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in Common Rheumatic Diseases: A Nationwide Population-Based Cohort Study.羟氯喹不会增加常见风湿性疾病中心律失常的风险：一项全国范围内基于人群的队列研究。
Front Immunol. 2021 Apr 2;12:631869. doi: 10.3389/fimmu.2021.631869. eCollection 2021.
8
Hydroxychloroquine: A double‑edged sword (Review).羟氯喹：一把双刃剑（综述）
Mol Med Rep. 2025 Apr;31(4). doi: 10.3892/mmr.2025.13467. Epub 2025 Feb 21.
9
Treatment adherence behaviours in rheumatic diseases during COVID-19 pandemic: a Latin American experience.COVID-19大流行期间风湿性疾病的治疗依从行为：拉丁美洲的经验
Ann Rheum Dis. 2021 Jun;80(6):e85. doi: 10.1136/annrheumdis-2020-218198. Epub 2020 Jun 23.
10
[Antimalarial preparations in rheumatology: new prospects].[抗疟制剂在风湿病学中的应用：新前景]
Ter Arkh. 1996;68(1):67-71.

引用本文的文献

1
Translating evidence into practice during the COVID-19 pandemic: pitfalls and mileages.在新冠疫情期间将证据转化为实践：陷阱与成效
Ther Adv Drug Saf. 2021 Mar 15;12:2042098621998876. doi: 10.1177/2042098621998876. eCollection 2021.